274 related articles for article (PubMed ID: 12023382)
1. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
2. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
Wajih N; Sane DC
Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
[TBL] [Abstract][Full Text] [Related]
4. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
5. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
6. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells.
Redlitz A; Daum G; Sage EH
J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071
[TBL] [Abstract][Full Text] [Related]
7. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin.
Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA
Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
9. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
Falcone DJ; Khan KM; Layne T; Fernandes L
J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases generate angiostatin: effects on neovascularization.
Cornelius LA; Nehring LC; Harding E; Bolanowski M; Welgus HG; Kobayashi DK; Pierce RA; Shapiro SD
J Immunol; 1998 Dec; 161(12):6845-52. PubMed ID: 9862716
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
[TBL] [Abstract][Full Text] [Related]
12. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
[TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
14. Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS
Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539
[TBL] [Abstract][Full Text] [Related]
15. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
[TBL] [Abstract][Full Text] [Related]
17. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
[TBL] [Abstract][Full Text] [Related]
18. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
20. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]